Evidence map›Paper›PMID 36442105›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

Local production of corticotropin-releasing hormone in prefrontal cortex modulates male-specific novelty exploration.

Michael H Riad, Kwanghoon Park, Ines Ibañez-Tallon, Nathaniel Heintz

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Pre-trauma cognitive traits predict fear generalization and associated prefrontal functioning in a longitudinal rodent model.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  6. Review
  7. Prefrontal corticotropin-releasing factor promotes resilience to social stress.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Michael H RiadLaboratory of Molecular Biology, Howard Hughes Medical Institute, The Rockefeller University, New York, NY 10065.
Kwanghoon ParkLaboratory of Molecular Biology, Howard Hughes Medical Institute, The Rockefeller University, New York, NY 10065.
Ines Ibañez-TallonLaboratory of Molecular Biology, Howard Hughes Medical Institute, The Rockefeller University, New York, NY 10065.ORCID 0000-0002-4908-4626
Nathaniel HeintzLaboratory of Molecular Biology, Howard Hughes Medical Institute, The Rockefeller University, New York, NY 10065.ORCID 0000-0002-8874-8704
Howard Hughes Medical Institute · US

Funding

Development of novel therapeutics for opioid dependenceUH3DA048385 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KAMENECKA, THEODORE M, KENNY, PAUL J. · 2020 to 2022
$5.9M
Development of novel therapeutics for opioid dependenceUG3DA048385 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KAMENECKA, THEODORE M, KENNY, PAUL J. · 2018 to 2019
$4.0M
Howard Hughes Medical InstituteNIDA NIH HHS UG3 DA048385NIDA NIH HHS UH3 DA048385
6 · The paper itself

Abstract

Neuromodulatory substances can be released from distal afferents for communication between brain structures or produced locally to modulate neighboring circuit elements. Corticotropin-releasing hormone (CRH) from long-range neurons in the hypothalamus projecting to the medial prefrontal cortex (mPFC) has been shown to induce anxiety-like behaviors. However, the role of CRH produced in the mPFC has not been investigated. Here we demonstrate that a specific class of mPFC interneurons that express CRH (CrhINs) releases CRH upon high-frequency stimulation to enhance excitability of layer 2/3 pyramidal cells (L2/3 PCs) expressing the CRH receptors. When stimulated at low frequency, CrhINs release GABA resulting in the inhibition of oxytocin receptor-expressing interneurons (OxtrINs) and L2/3 PCs. Conditional deletion of CRH in mPFC CrhINs and chemogenetic activation of CrhINs have opposite effects on novelty exploration in male but not in female mice, and do not affect anxiety-related behaviors in either males or females. Our data reveal that CRH produced by local interneurons in the mPFC is required for sex-specific novelty exploration and suggest that our understanding of complex behaviors may require knowledge of local and remote neuromodulatory action.

Indexed as

Corticotropin-Releasing HormonePrefrontal CortexAnimalsFemaleInterneuronsMaleMicePyramidal CellsReceptors, Corticotropin-Releasing HormoneCorticotropin-Releasing HormoneReceptors, Corticotropin-Releasing Hormonecircuit modulationcorticotropin releasing hormonemedial prefrontal cortexnovelty explorationsexual dimorphic

Identifiers

PMID36442105
PMCPMC9894189
OpenAlexW4310102564

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.